Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice‐site and Charcot‐Marie‐Tooth phenotype with early onset symptoms
Authors:
- Thomas A. CassiniTCThomas A. Cassini
- John H. NewmanJNJohn H. Newman
- Undiagnosed Diseases NetworkUNUndiagnosed Diseases Network
Open Access
- 25 April 2019
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (6) , e00676
Abstract
Background: Rare variants (RV) in immunoglobulin mu‐binding protein 2 (IGHMBP2) [OMIM 600502] can cause an autosomal recessive type of Charcot‐Marie‐Tooth (CMT) disease [OMIM 616155], an inherited peripheral neuropathy. Over 40 different genes are associated with CMT, with different possible inheritance patterns.Methods and Results: An 11‐year‐old female with motor delays was found to have distal atrophy, weakness, and areflexia without bulbar or sensory findings. Her clinical evaluation was unrevealing. Whole exome sequencing (WES) revealed a maternally inherited IGHMBP2 RV (c.1730T>C) predicted to be pathogenic, but no variant on the other allele was identified. Deletion and duplication analysis was negative. She was referred to the Undiagnosed Disease Network (UDN) for further evaluation.Whole genome sequencing (WGS) confirmed the previously identified IGHMBP2 RV and identified a paternally inherited non‐coding IGHMBP2 RV. This was predicted to activate a cryptic splice site perturbing IGHMBP2 splicing. Reverse transcriptase polymerase chain reaction (RT‐PCR) analysis was consistent with activation of the cryptic splice site. The abnormal transcript was shown to undergo nonsense‐mediated decay (NMD), resulting in halpoinsufficiency.Conclusion: This case demonstrates the deficiencies of WES and traditional molecular analyses and highlights the advantages of utilization of WGS and functional studies.Keywords
Funding Information
- National Human Genome Research Institute (UO1HG007674)
This publication has 14 references indexed in Scilit:
- Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal DiseaseThe American Journal of Human Genetics, 2017
- Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2Neuromuscular Disorders, 2016
- Autosomal recessive axonal polyneuropathy in a sibling pair due to a novel homozygous mutation in IGHMBP2Neuromuscular Disorders, 2015
- Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1Journal of Cellular and Molecular Medicine, 2015
- Recessive truncating IGHMBP2 mutations presenting as axonal sensorimotor neuropathyNeurology, 2015
- Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2The American Journal of Human Genetics, 2014
- The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1Nucleic Acids Research, 2012
- IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)Human Molecular Genetics, 2009
- Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1Nature Genetics, 2001
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001